Annovis Bio (ANVS) Assets (2019 - 2026)
Annovis Bio's Assets came in at $22.04 million for Q2 2026, up 2.7% from $21.45 million a year earlier and up 35.7% from the prior quarter.
Powered by 
Analysis
Annovis Bio (ANVS) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Annovis Bio's Assets was $21.08 million, up 51.4% from FY2024.
- Assets carries a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
- Going back by year, Assets was $13.93 million in FY2024 (+36.4%), $10.21 million in FY2023 (-71.7%), $36.02 million in FY2022 (-21.7%) and $46 million in FY2021 (+466.6%).
- The Q2 2026 figure represents the highest quarterly Assets since Q1 2025.
- Year-over-year, Assets increased in seven of the last eight quarters, with growth averaging 84.8%.
- The fastest year-over-year change in Assets over five years came in Q1 2022 (growth of 639.3%), and the weakest in Q2 2024 (a decline of 77.9%).
- Business Quant data shows ANVS's Assets at $16.24 million (Q1 2026), $21.08 million (Q4 2025) and $17.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Annovis Bio | 58.80 Mn | 58.80 Mn | - | 22.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.04 Mn |
| Mar 31, 2026 | 16.24 Mn |
| Dec 31, 2025 | 21.08 Mn |
| Sep 30, 2025 | 17.19 Mn |
| Jun 30, 2025 | 21.45 Mn |
| Mar 31, 2025 | 26.74 Mn |
| Dec 31, 2024 | 13.93 Mn |
| Sep 30, 2024 | 14.36 Mn |
| Jun 30, 2024 | 5.05 Mn |
| Mar 31, 2024 | 7.81 Mn |
| Dec 31, 2023 | 10.21 Mn |
| Sep 30, 2023 | 10.22 Mn |
| Jun 30, 2023 | 22.82 Mn |
| Mar 31, 2023 | 25.55 Mn |
| Dec 31, 2022 | 36.02 Mn |
| Sep 30, 2022 | 37.12 Mn |
| Jun 30, 2022 | 39.97 Mn |
| Mar 31, 2022 | 44.10 Mn |
| Dec 31, 2021 | 46.00 Mn |
| Sep 30, 2021 | 47.65 Mn |
API Access
Annovis Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();